Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Kelly

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 2, 2025
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancerBrian M Slomovitz, Natalie Danziger, Julia C F Quintanilha, et al.
BMC Genomics|July 25, 2012
A microRNA activity map of human mesenchymal tumors: connections to oncogenic pathways; an integrative transcriptomic studyElena Fountzilas, Andrew D Kelly, Antonio R Perez-Atayde, et al.
Genome Medicine|January 24, 2013
MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32Andrew D Kelly, Benjamin Haibe-Kains, Katherine A Janeway, et al.
Communications Biology|March 9, 2022
Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcomaChristopher E Lietz, Erik T Newman, Andrew D Kelly, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
A dynamic microRNA profile that tracks a chemotherapy resistance phenotype in osteosarcoma. Implications for novel therapeuticsChristopher E Lietz, Erik T Newman, Andrew D Kelly, et al.
Journal of Hematology & Oncology|May 17, 2017
An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasetsKatherine E Hill, Andrew D Kelly, Marieke L Kuijjer, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 2, 2025
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancerBrian M Slomovitz, Natalie Danziger, Julia C F Quintanilha, et al.
BMC Genomics|July 25, 2012
A microRNA activity map of human mesenchymal tumors: connections to oncogenic pathways; an integrative transcriptomic studyElena Fountzilas, Andrew D Kelly, Antonio R Perez-Atayde, et al.
Genome Medicine|January 24, 2013
MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32Andrew D Kelly, Benjamin Haibe-Kains, Katherine A Janeway, et al.
Communications Biology|March 9, 2022
Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcomaChristopher E Lietz, Erik T Newman, Andrew D Kelly, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
A dynamic microRNA profile that tracks a chemotherapy resistance phenotype in osteosarcoma. Implications for novel therapeuticsChristopher E Lietz, Erik T Newman, Andrew D Kelly, et al.
Journal of Hematology & Oncology|May 17, 2017
An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasetsKatherine E Hill, Andrew D Kelly, Marieke L Kuijjer, et al.
Pageof 2